This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Shin Poong Pharmaceutical Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Chung Ju in Pharmaceutical Composition
Introduction
Chung Ju is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at combating viral infectious diseases.
Latest Patents
Chung Ju holds a patent for a pharmaceutical composition designed for preventing or treating epidemic RNA viral infectious diseases. This invention specifically addresses the Coronavirus Disease 2019 (COVID-19). The composition includes pyronaridine or a pharmaceutically acceptable salt thereof, and/or artemisinin or a derivative thereof, combined with a pharmaceutically acceptable carrier. This innovative approach aims to provide effective treatment options during viral outbreaks.
Career Highlights
Chung Ju is associated with Shin Poong Pharmaceutical Co., Ltd., where he continues to work on groundbreaking pharmaceutical solutions. His dedication to research and development has positioned him as a key figure in the fight against viral diseases.
Collaborations
Chung Ju collaborates with esteemed colleagues such as Jei Man Ryu and Hyun Kyu Chung. Their combined expertise enhances the potential for innovative breakthroughs in the pharmaceutical industry.
Conclusion
Chung Ju's contributions to pharmaceutical innovations, particularly in the context of viral infectious diseases, underscore the importance of research in public health. His work exemplifies the critical role of inventors in developing solutions to global health challenges.